← Back to Search

Procedure

Needle Comparison for Diagnosing Sarcoidosis

N/A
Recruiting
Led By Kazuhiro Yasufuku
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients that are unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial wants to see if using Franseen-type needles for sample collection can help diagnose sarcoidosis better than the conventional Menghini-type needle.

Who is the study for?
This trial is for individuals with sarcoidosis, a condition where tiny clumps of inflammatory cells grow in different parts of the body. Participants should be suitable candidates for a procedure called EBUS-TBNA, which collects tissue samples from the lungs.
What is being tested?
The study is testing two types of needles used in EBUS-TBNA: Franseen-type and Menghini-type. It aims to determine if the Franseen needle provides better quality samples for diagnosing sarcoidosis compared to the conventional Menghini needle.
What are the potential side effects?
EBUS-TBNA may cause coughing, bleeding at puncture sites, infection risk, shortness of breath or discomfort during and after the procedure. The side effects can vary based on individual patient factors.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to understand or sign the consent form.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of adequate tissue sampling from lymph nodes (as determined by pathologists)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Menghini-type needleExperimental Treatment1 Intervention
the standard needle type
Group II: Franseen-type needlesActive Control1 Intervention
the active comparator arm

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,194 Total Patients Enrolled
1 Trials studying Sarcoidosis
40 Patients Enrolled for Sarcoidosis
Kazuhiro YasufukuPrincipal InvestigatorUHN
~60 spots leftby Feb 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top